July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Diagnostic accuracy of OCTA vessel density and OCT tissue thickness measurements using machine learning
Author Affiliations & Notes
  • Christopher Bowd
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Linda M Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Michael Henry Goldbaum
    Jacobs Retina Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Elham Ghahari
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Huiyuan Hou
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Sasan Moghimi
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Rafaella Penteado
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Robert N Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Christopher Bowd, None; Akram Belghith, None; Linda Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering GmbH (F), Heidelberg Engineering GmbH (R), Optovue Inc, (F), Topcon Medical Systems Inc. (F); Michael Goldbaum, None; Mark Christopher, None; Elham Ghahari, None; Huiyuan Hou, None; Sasan Moghimi, None; Rafaella Penteado, None; Robert Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch & Lomb (F), Carl Zeiss Meditec Inc. (F), Centervue (F), Eyenovia (C), Genentech (F), Implantdata (C), Konan (F), Meditec-Zeiss (P), Optos (F), Optovue (F), Sensimed (C), Topcon (F), Toromedes (P), Unity (C), Valient (C)
  • Footnotes
    Support  NEI Grants R21EY022039, R21EY027945, R01EY029058, R01EY011008, R01027510, 026574, T32EY026590, P30EY022589, participant retention incentive grants in the form of glaucoma medication at no cost from Novartis/Alcon Laboratories Inc, Allergan, Akorn, and Pfizer Inc. and an unrestricted grant from Research to Prevent Blindness, New York, New York,
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3044. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher Bowd, Akram Belghith, Linda M Zangwill, Michael Henry Goldbaum, Mark Christopher, Elham Ghahari, Huiyuan Hou, Sasan Moghimi, Rafaella Penteado, Robert N Weinreb; Diagnostic accuracy of OCTA vessel density and OCT tissue thickness measurements using machine learning. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3044. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare gradient boosting classifier model (GBM) analysis of OCTA-measured vessel density (VD) and OCT-measured tissue thickness to software generated parameters for classifying healthy and glaucomatous eyes.

Methods : 100 eyes of 51 healthy participants and 264 glaucomatous eyes of 185 patients from the Diagnostic Innovations in Glaucoma Study who underwent OCTA and OCT (OptoVue Avanti with AngioVue software) imaging of the macula and ONH were enrolled in this observational cross-sectional study. GBMs were trained independently on 1) all exportable macula VD measurements, 2) all exportable peripapillary VD measurements, 3) all exportable macula thickness (GCC) measurements, and 4) all exportable peripapillary thickness measurements from 69 healthy eyes and 188 glaucoma eyes. The discrimination power of GBM measurements was assessed using an independent dataset composed of 31 healthy eyes and 76 glaucomatous eyes. GBM VD classifications were compared to superficial whole image macular VD, whole image capillary density (CD, with large vessel removal) and peripapillary CD classifications and GBM tissue thickness classifications were compared to global GCC thickness and global peripapillary RNFL thickness by comparing ROC curve areas (AUROCs).

Results : The glaucoma test group was significantly older [mean (95% CI) 71.9 (68.7, 75.1) and 59.5 (53.4, 65.6) years, respectively, P < 0.001) and had worse visual field MD [-6.9 (-8.5, -5.2) dB and -0.53 (-0.2, 0.8) dB, respectively, P < 0.001) compared to the healthy test group. AUROCs with associated 95% CIs for the investigated GBM analyses and the instrument provided parameters are shown in the figures below. GBM peripapillary VD results were similar to or better than instrument provided VD parameter results and GBM RNFL thickness results were better than instrument provided thickness parameter results. Peripapillary VD-based GBM delivered the best classification performance (all p < 0.05). Classification performance of macular VD-based and macular thickness-based GBMs was worse than classification performance of peripapillary VD-based and RNFL thickness-based GBM models (all P < 0.05).

Conclusions : Machine learning gradient boosting models improve glaucoma diagnostic accuracy of OCTA measurements compared to individual instrument provided parameters. Such techniques could be incorporated into instrument software to improve clinical usefulness.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×